Allied Academies invites all the participants from all over the world to attend “International Conference on Obstetrics and Gynecology” Which is to be held in LAS VEGAS, USA on OCTOBER 5th – 6th, 2017 which includes prompt Keynote Presentations, Special Sessions, Workshops, Symposiums, Oral talks, Poster Presentations and Exhibitions.
Theme: Caring for women at every stage of their lives
Obstetrics & Gynecology 2017 offers a cutting edge program of renowned international speakers and specialists, concurrent sessions, oral and poster presentations attracting over 200 experts in fertility, assisted conception, sexual health and reproductive biology and gynecology field. This conference has been carefully designed to meet the unique educational needs of Gynecologists. Obstetrics & Gynecology 2017 has been made in an interdisciplinary manner with various tracks to choose from every segment and provides you a unique opportunity to meet up with peers from both industry and academia and establish a scientific network among. We cordially invite to join us at our event and make it successful by your participation.
A comprehensive range of topics will be discussed in the event including maternal fetal medicine, gynecology oncology, Sexual medicine, Substance Use & abuse, ultrasound diagnosis, Menstruation, Leukoaraiosis, Endometriosis, Body Mass Index, genitourinary medicine, and Gynecologic Cancers. It is our ideology to bring maximum exposure to our attendees, so we make sure the event is a blend which covers professionals such as gynecologists, obstetricians, veteran researchers, Women healthcare professionals from academia and industry making the conference a perfect platform.
Allied Academies was founded by Jim and JoAnn Carland and the headquarters is located in North Carolina in United States of America. It conducts several academic conferences each year in different locations with internet participation possibilities for those who are physically unable to attend the conferences. Conference registrants are eligible for the Accelerated Journal Review. To provide you with maximum outlets for your research, Allied Business Academies holds joint meetings of all its member academies. In 1994 they launched the Journal of the International Academy of Case Studies, which has become a leader in publishing classroom teaching cases in business.
Why to attend???
With members from around the world focused on learning about Women’s Health and its advances, this is your best opportunity to reach the largest assemblage of participants from the Women’s Health community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new discoveries in the breast cancer treatment and diagnosis, and receive name recognition at this 2-days event. World-renowned speakers, the most recent techniques, developments, and the newest updates in women’s health, breast cancer, gynecological issues, pregnancy, Woman Psychology, women disorders are hallmarks of this conference.
Las Vegas, USA
Go along with us for the advising occasion of the year. Participants can acquire CME through a wide assortment of auspicious learning sessions; exploit effective learning openings, for example, the Grad Students and New Professionals Only Sequence; Collaborate with directing associates from around the globe; pick up vocation experiences and additionally leads at the OB-GYN Summit 2017
Going to the OB-GYN Summit 2017 Conference is an interest in your vocation. There's no better approach to exhibit your dedication to the advising calling than to upgrade your aptitudes, improve your insight base, and expand your viewpoints - all in one extremely extraordinary place!
The sessions include Obstetrics, Gynecology, Reproductive Biology, Heredities in Obs and Gyn, Treatments in Pregnancy, Breast Disease, Prenatal Diagnosis, Midwifery, Gynecology & surgical procedure, Gynecologic cancers, Critical care in women health, Contraception, Health related Behaviours In Women, Infertility, Family planning, Reproductive Medicine, Nursing and Health care, Gynecological Endocrinology, Uro gynecology, Maternal-fetal medicine, Sexually transmitted Disease, Menopausal and geriatric gynecology
- 200+ Participation (70 Industry: 30 Academia)
- 5+ Keynote Speakers
- 50+ Plenary Speakers
- 10+ Exhibitors
- 12 Innovative Educational Sessions
- 5+ Workshops
- B2B Meetings
Allied Academics feels proud and pleasure to invite Research Scientists, Obstetricians, Gynecologists, Professors, Students and Healthcare Diagnostics to attend the "International Conference on “Obstetrics & Gynecology" to be held atlas LAS VEGAS, USA during OCTOBER 5th & OCTOBER 6th,2017.
Allied Academics has been instrumental in Conducting International Meetings for 20 years and very excited to expand in Medical and health Care Fields. Allied Academics promotes peer reviewed healthcare information through meetings, scholarly journals, and training to leading academic, business and research institutes across the healthcare and life science industries.
Obstetrics and Gynecology is the medical specialty that deals with obstetrics and gynecology. The postgraduate training program for both aspects is unified. This combined training prepares the practicing OB-GYN to be adept at the care of female reproductive organs' health and at the management of pregnancy. Gynecology is the specialized field of medicine dealing with the health of a woman's genital system. The genital system consists of the reproductive organs, including the uterus (the womb; the organ in which a fetus develops), cervix (the opening between the uterus and the vagina), ovaries (organs that produce eggs and sex hormones), Fallopian tubes (organs that carry eggs from the ovaries to the uterus), vagina (the muscular tube that extends from the uterus to outside the body), as well as their supporting structures. Obstetrics is the field of study concentrated on pregnancy, childbirth, and the postpartum period. As a medical specialty, obstetrics is combined with gynecology under the discipline known as obstetrics and gynecology.
Midwifery encompasses care of
women during pregnancy, labour and the postpartum period, as well as care of
the new-born and the one who is a health science and health profession that
deals with pregnancy, childbirth, and the postpartum period. It includes measures
aimed at preventing health problems in pregnancy, the detection of abnormal
conditions, the procurement of medical assistance when necessary, and the
execution of emergency measures in the absence of medical help.
Midwifery, as known as obstetrics, is a health science and health profession that deals with pregnancy, childbirth, and the postpartum period (including care of the newborn), besides sexual and reproductive health of women throughout their lives. In many countries, midwifery is a medical profession (special for its independent and direct specialized education; should not be confused with a medical specialty, which depends on a previous general training).A professional in midwifery is known as a midwife.
Urogynecology is a
sub-specialty of urology and Gynecology and in some countries is also known as
Female Pelvic Medicine and Reconstructive Surgery. An urogynecologist manages
clinical problems associated with dysfunction of the pelvic floor and bladder.
Pelvic floor disorders affect the bladder, reproductive organs, and bowels. It
refers to the study and management of structural and functional changes of the
urological system in female.
The study of the maternal
female hormone system includes the activities of the hypothalamus, pituitary,
and ovaries from puberty through menopause. Women may suffering from multiple
miscarriages, an inability to conceive, abnormally heavy or irregular periods,
fibroids or discomfort related to menopause are considered to have
Gynecological endocrinology disorders. Gynecological endocrinologists deal with
a wide range of reproductive disorders as well.
Gynecologic oncology is a
specialized field of medicine that focuses on cancers of the female
reproductive system, including ovarian cancer, uterine cancer, vaginal cancer,
cervical cancer, and vulvar cancer. Cancer of the female reproductive tract
also includes the endometrium, fallopian tubes, and vagina. The specialists in
this do have extensive training in the diagnosis and treatment of these cancers.
Genitourinary is the branch of
medical science concerned with the study and treatment of diseases of the
genital and urinary organs, especially sexually transmitted diseases. Sexual
health or genitourinary medicine (GUM) clinics offer a range of services,
including: testing and treatment for sexually transmitted infections (STIs)
advice and information about sexual health.
The field cooperates with and
overlaps mainly with reproductive endocrinology and infertility, sexual
medicine and andrology, but also to some degree with gynecology, obstetrics,
urology, genitourinary medicine, medical endocrinology, pediatric
endocrinology, genetics, and psychiatry. Reproductive medicine is a branch of
medicine that deals with prevention, diagnosis and management of reproductive
problems; goals include improving or maintaining reproductive health and
allowing people to have children at a time of their choosing. It is founded on
knowledge of reproductive anatomy, physiology, and endocrinology, and
incorporates relevant aspects of molecular biology, biochemistry and pathology.
It addresses issues of sexual education, puberty, family planning, birth
control, infertility, reproductive system disease (including sexually
transmitted diseases) and sexual dysfunction. In women, reproductive medicine
also covers menstruation, ovulation, pregnancy and menopause, as well as
gynecologic disorders that affect fertility.
Prenatal diagnosis and prenatal
screening are aspects of prenatal care that focus on detecting anatomic and
physiologic problems with the zygote, embryo, or fetus as early as possible,
either before gestation even starts (as in pre-implantation genetic diagnosis)
or as early in gestation as practicable. It is a way for a doctor to determine,
before birth, whether the fetus has a problem such as Down syndrome. The
screening focuses on finding problems among a large population with affordable
and noninvasive methods, whereas the diagnosis focuses on pursuing additional
detailed information once a particular problem has been found, and can
sometimes be more invasive. Screening can also be used for prenatal sex
discernment. Amniocentesis and chorionic villus sampling (CVS) are tests that
help find genetic disorders before birth. Common testing procedures include,
ultrasonography including nuchal translucency ultrasound, serum biomarker
testing, or genetic screening. In some cases, the tests are administered to
determine if the fetus will be aborted, though physicians and patients also
find it useful to diagnose high-risk pregnancies early so that delivery can be
scheduled in a tertiary care hospital where the baby can receive appropriate
Family planning is sometimes
used as a synonym or euphemism for access to and the use of contraception.
However, it often involves methods and practices in addition to contraception.
Family planning is the practice of controlling the number of children in a
family and the intervals between their births, particularly by means of
artificial contraception or voluntary sterilization. Because "family"
is included in the concept's name, consideration of a couple's desire to bear
children, in the context of a family unit, is often considered primarily.
Contemporary notions of family planning, however, tend to place a woman and her
childbearing decisions at the center of the discussion, as notions of women's
empowerment and reproductive autonomy have gained traction in many parts of the
world. Family planning may involve consideration of the number of children a
woman wishes to have, including the choice to have no children, as well as the
age at which she wishes to have them. These matters are obviously influenced by
external factors such as marital situation, career considerations, financial
position, and any disabilities that may affect their ability to have children
and raise them, besides many other considerations. If sexually active, family
planning may involve the use of contraception and other techniques to control
the timing of reproduction.
Track 10: Menopause
Menopause, also known as the
climacteric, is the time in most women's lives when menstrual periods stop
permanently, and they are no longer able to bear children. Menopause typically
or usually occurs naturally, most often after age 45 or between 49 and 52 years
of age. Medical professionals often define menopause as having occurred when a
woman has not had any vaginal bleeding for a year. It may also be defined by a
decrease in hormones (like estrogen and progesterone) production by the
ovaries. In those who have had surgery to remove their uterus but they still
have ovaries, menopause may be viewed to have occurred at the time of the
surgery or when their hormone levels fell.
Gynecological surgery or
Operative Gynecology refers to surgery on the female reproductive system.
Gynecological surgery is usually performed by gynecologists. It includes
procedures for benign conditions, cancer, infertility, and incontinence.
Gynecological surgery may occasionally be performed for elective or cosmetic
Infertility is the inability of
a person, animal or plant to reproduce by natural means. It is usually not the
natural state of a healthy adult organism, except notably among certain
eusocial species. In humans, infertility may describe a woman who is unable to
conceive as well as being unable to carry a pregnancy to full term. There are
many biological and other causes of infertility, including some that medical
intervention can treat. It refers to an inability to conceive after having
regular unprotected sex. Infertility can also refer to the biological inability
of an individual to contribute to conception, or to a female who cannot carry a
pregnancy to full term. In many countries infertility refers to a couple that
has failed to conceive after 12 months of regular sexual intercourse without
the use of contraception.
Women's health or wellbeing
alludes to the soundness of ladies, which varies from that of men in numerous
novel ways. Ladies' wellbeing is a case of populace wellbeing, where wellbeing
is characterized by the World Health Organization as "a condition of
finish physical, mental and social prosperity and not just the nonattendance of
sickness or ailment". Regularly regarded as just ladies' conceptive wellbeing,
many gatherings contend for a more extensive definition relating to the general
soundness of ladies, better communicated as "The strength of ladies".
These distinctions are further exacerbated in creating nations where ladies,
whose wellbeing incorporates both their dangers and encounters, are further
Maternal supplements refer to
the nutrient intake, and dietary planning that is undertaken before, during and
after pregnancy. Nutrition of the fetus begins at conception. For this reason,
the nutrition of the mother is important from before conception (probably
several months before) as well as throughout pregnancy and breast feeding. An
ever-increasing number of studies have shown that the nutrition of the mother
will have an effect on the child, up to and including the risk for cancer,
cardiovascular disease, hypertension and diabetes throughout life. An
inadequate or excessive amount of some nutrients may cause malformations or
medical problems in the fetus, and neurological disorders and handicaps are a
risk that is run by mothers who are malnourished. A high number of babies
worldwide are estimated to be born with lower than optimal weights at birth due
to lack of proper nutrition. Even personal habits such as smoking, alcohol,
caffeine, using certain medications and street drugs can negatively and
irreversibly affect the development of the baby, which happens in the early
stages of pregnancy.
Abortion, basically of two
types: induced and spontaneous, is the ending of pregnancy by removing a fetus
or embryo before it can survive outside the uterus. An abortion that occurs
spontaneously is also known as a miscarriage. An abortion may be caused
purposely and is then called an induced abortion, or less frequently,
"induced miscarriage". The word abortion is often used to mean only
induced abortions. A similar procedure after the fetus could potentially
survive outside the womb is known as a "late termination of
An ectopic pregnancy is a
pregnancy that occurs outside the uterine cavity and usually in the fallopian
tube. When the fertilized egg implants in the fallopian tube or somewhere else
in the abdomen, it ends up with what’s called an ectopic pregnancy. It is also
known as eccyesis or tubal pregnancy, possessing a complication of pregnancy in
which the embryo attaches outside the uterus. Signs and symptoms classically
include abdominal pain and vaginal bleeding. In these cases, the pregnancy
can’t continue normally, and it requires emergency treatment.
Besides pregnancy, there are
several causes of an enlarged uterus. Two of the most common causes are uterine
fibroids and adenomyosis. Uterine fibroids are common, non-cancerous tumors of
the muscular wall of the uterus, affecting as many as eight in 10 women by the
age of 50. The uterus sometimes may increase to double or triple its normal
size with adenomyosis. It usually occurs after women have had children, and it
disappears after menopause. Adenomyosis is a normally benign, but often painful
condition where endometrial tissue, which normally lines the uterus, exists
inside the uterus and grows into it’s the muscular walls.
Birth control, also known as
contraception and fertility control or preservation, is a method or device used
to prevent pregnancy. Birth control has been used since ancient times, but
effective and safe methods of birth control only became available in the 20th
century. Planning, making available and using birth control is called family
planning. Some cultures limit or discourage access to birth control because
they consider it to be morally, religiously, or politically undesirable. The
most effective methods of birth control are sterilization by means of vasectomy
in males and tubal ligation in females, intrauterine devices (IUDs), and
implantable birth control.
If a woman is pregnant or might
become pregnant, it's critically important to get enough folic acid, the
synthetic form of vitamin B9, also known as folate. Folic acid helps prevent
neural tube defects (NTDs) – serious birth defects of the spinal cord (such as
spina bifida) and the brain (such as anencephaly).
In vitro fertilization (or
fertilization; IVF) is a type of assisted reproductive technology used for
infertility treatment and gestational surrogacy in cases like: Blocked or
damaged fallopian tubes; Male factor infertility including decreased sperm count
or sperm motility. It is a process by which an egg is fertilized by sperm
outside the body: in vitro ("in glass"). The process involves
monitoring and stimulating a woman's ovulatory process, removing an ovum or ova
(egg or eggs) from the woman's ovaries and letting sperm fertilize them in a
liquid in a laboratory. The fertilised egg (zygote) is cultured for 2–6 days in
a growth medium and is then transferred to the same or another woman's uterus,
with the intention of establishing a successful pregnancy.
Intrauterine insemination (IUI)
is a fertility treatment that involves placing sperm inside a woman's uterus to
facilitate fertilization. The goal of IUI is to increase the number of sperm
that reach the fallopian tubes and subsequently increase the chance of
fertilization. IUI is commonly used for unexplained infertility. It is
also used for couples affected by mild endometriosis, problems with ovulation,
mild male factor infertility and cervical factor infertility. Insemination is a
reasonable initial treatment that should be utilized for a maximum of about 3
months in women who are ovulating (releasing eggs) on their own. It is
reasonable to try IUI for longer in women with polycystic ovaries (PCOS) and
lack of ovulation that have been given drugs to ovulate.
Misconceptions are very common
in the world of infertility. One popular myth is that infertility is the
woman's problem and that once that "problem" is fixed; the couple
will be able to conceive. This could not be farther from the truth. In fact, in
nearly 30% of all infertility cases, the cause is attributed to a factor in the
male and in an additional 30% of cases the cause is attributed to both male and
female factors. Less than a decade ago, treatment for a severe male factor was
limited to inseminations or IVF using donor sperm. Today, exciting advances in
male infertility have introduced innovative therapeutic options that offer men,
including those with no sperm in their ejaculate due to genetic conditions, a
greatly improved chance to conceive their own biological offspring. Male factor
problems essentially fall into one of two categories: productive or
obstructive. Problems with sperm production can stem from congenital (present
at birth) problems with the testicle, hormone-related issues, varicose veins,
environmental exposures, or cancer. In these cases, a detailed consultation
with a reproductive endocrinologist or reproductive urologist can help pinpoint
potential causes as well as facilitate treatment with the intent of improving a
Ovulation is the point at which
a develop egg is discharged from the ovary, pushed down the fallopian tube, and
is made accessible to be treated. Roughly consistently an egg will develop
inside one of your ovaries. As it achieves development, the egg is discharged
by the ovary where it enters the fallopian tube to advance towards sitting
tight for sperm and the uterus. In other words Ovulation is the arrival of egg
from the ovaries. In people, this occasion happens when the de Graff’s
follicles crack and discharge the auxiliary oocyte ovarian cells. After
ovulation, amid the luteal stage, the egg will be accessible to be prepared by
sperm. What's more, the uterine coating (endometrium) is thickened to have the
capacity to get a prepared egg. In the event that no origination happens, the
uterine coating and in addition blood will be shed amid feminine cycle.
Pelvic provocative ailment or
pelvic inflammatory disease (PID) is a disease of the upper piece of the female
conceptive framework in particular the uterus, fallopian tubes, and ovaries,
and within the pelvis. Often there might be no symptoms. Signs and indications,
when present may incorporate lower stomach torment, vaginal release, fever,
consuming with pee, torment with sex, or sporadic menstruation. Untreated
PID can bring about long haul entanglements including barrenness, ectopic
pregnancy, incessant pelvic torment, and cancer. The ailment is brought on by
microscopic organisms that spread from the vagina and cervix. Infections by
Neisseria gonorrhoea or Chlamydia trachomatis are available in 75 to 90 per
cent of cases. Frequently numerous distinctive microbes are involved. Without
treatment around 10 per cent of those with a chlamydial disease and 40 per cent
of those with a gonorrhoea contamination will create PID. Risk components are
like those of sexually transmitted diseases for the most part and incorporate a
high number of sexual accomplices and medication utilize. Vaginal douching may
likewise build the hazard. The determination is ordinarily in view of the
showing signs and side effects. It is suggested that the ailment be considered
in all ladies of childbearing age who have bring down stomach torment. A
complete analysis of PID is made by discovering discharge including the
fallopian tubes amid surgery. Ultrasound may likewise be valuable in diagnosis.
The pituitary organ is a
pea-sized organ at the base of the cerebrum. The pituitary is the "ace
control organ" - it produces numerous hormones that go all through the
body, coordinating certain procedures or fortifying different organs to deliver
different hormones & makes hormones that influence development and the
elements of different organs in the body. The pituitary organ makes or stores a
wide range of hormones. With pituitary issue, one frequently have excessively
or too little of one of their hormones. Wounds can bring about pituitary issue,
yet the most widely recognized cause is a pituitary tumour.
Polycystic ovary syndrome
(PCOS) is a hormonal condition that affects how your ovaries work. Usually,
about five follicles start to mature during each menstrual cycle. At least one
follicle releases a mature egg at ovulation. A polycystic ovary starts to
mature at least twice as many follicles as normal, most of which enlarge and
ripen but do not release an egg. It is estimated that between 22 and 33 per
cent of women have polycystic ovaries. Some women go on to develop polycystic
ovary syndrome (PCOS), which means they have other symptoms in addition to
polycystic ovaries. PCOS happens when their hormonal system gets out
of balance, making ovulation rare or irregular, and causing other changes in
the body. Polycystic ovary syndrome is estimated to affect between five and 15
per cent of women of reproductive age, and it is thought to be more common in
women of Asian descent. The exact cause of the problem is unknown but
it's likely to be a combination of factors. Genetics are involved, as PCOS
tends to run in families. Having higher than normal levels of the hormone
insulin in your body is linked to PCOS.
analysis (PGD or PIGD) alludes to the hereditary profiling of incipient
organisms preceding implantation (as a type of fetus profiling), and now and
again even of oocytes before treatment. PGD is considered in a comparable
manner to pre-birth analysis. At the point when used to screen for a particular
hereditary malady, its primary preference is that it stays away from specific
pregnancy end as the technique makes it exceedingly likely that the infant will
be free of the infection under thought. PGD in this manner is a subordinate to
helped conceptive innovation, and requires in vitro preparation (IVF) to get
oocytes or incipient organisms for assessment.
Reproductive Endocrinology and
barrenness (REI) is a surgical subspecialty of obstetrics and gynaecology that
trains doctors in conceptive medication tending to hormonal working in
accordance with generation and the issue of fruitlessness. While most REI
authorities principally concentrate on the treatment of fruitlessness,
regenerative endocrinologists are prepared to likewise assess and treat
hormonal dysfunctions in females and guys outside barrenness. Regenerative endocrinologists
have claim to fame preparing in obstetrics and gynaecology (ob-gyn) before they
experience sub-strength preparing (association) in REI.
Thyroid disorders are
conditions that affect the thyroid gland, a butterfly-shaped gland in the front
of the neck. The thyroid has important roles to regulate numerous metabolic
processes throughout the body. Different types of thyroid disorders affect
either its structure or function. The thyroid gland is located below the Adam's
apple wrapped around the trachea (windpipe). A thin area of tissue in the
gland's middle, known as the isthmus, joins the two thyroid lobes on each side.
The thyroid uses iodine to produce vital hormones. Thyroxine, also known as T4,
is the primary hormone produced by the gland. After delivery via the
bloodstream to the body's tissues, a small portion of the T4 released from the
gland is converted to triiodothyronine (T3), which is the most active hormone.
The function of the thyroid gland is regulated by a feedback mechanism
involving the brain.
Tubal factor infertility (TFI)
is female infertility caused by diseases, obstructions, damage, scarring,
congenital malformations or other factors which impede the descent of a
fertilized or unfertilized ovum into the uterus through the Fallopian tubes and
prevents a normal pregnancy and full term birth. Tubal factors cause 25-30% of
infertility cases. Tubal factor is one complication of Chlamydia trachomatis
infection in women.
Sexually transmitted Chlamydia and genital mycoplasma infections are preventable causes of infertility and negative pregnancy outcomes. When the infections progress and ascend, they can result in TFI. Infertility can have multiple possible causes and may not be recognized for years after gonorrhoea, Chlamydia or Mycoplasma infection has caused tubal damage, as the affected woman may not have attempted to become pregnant until years later. A blockage in the fallopian tubes will not allow the egg and sperm to meet. Tubal factor infertility accounts for about 25-30% of all cases of infertility. The condition includes cases of completely blocked fallopian tubes and cases where just one is blocked tube or scarring narrows the tubes.
Endometritis is a kind of
uterine infections which is an inflammation or irritation of the lining of the
uterus (the endometrium). It is not the same as endometriosis. Endometritis is
caused by an infection in the uterus. It can be due to chlamydia, gonorrhoea,
tuberculosis, or a mix of normal vaginal bacteria. It is more likely to occur
after miscarriage or childbirth. It is also more common after a long labor or
C-section. Endometritis is an inflammatory condition of the lining of the
uterus, and it’s usually due to an infection. The uterus, or womb, is a major
reproductive organ in women. It’s where the fetus develops during pregnancy.
Uterine Infection is usually not life-threatening, but it’s important to get it treated. It will generally go away when treated with antibiotics. Untreated infections can lead to complications with the reproductive organs, problems with fertility, and other general health problems.
World Market for
Gynecology, 2007-2017 provides a unique assessment of current developments and
prospective factors that will shape the global female health market over the
next decade. This unrivalled, in-depth market research study commissioned by
one of the top three multinational pharmaceutical companies presents a detailed
and comprehensive analysis of prescription products used in the diverse areas
of infertility, contraception, gynecological disorders, and menopause.
The market for gynecology is predicated on hormonal drugs that have recently been subject to controversy based on reports of associated increased risks of cardiovascular disease and cancer. The global market has suffered as a consequence due to cautious prescribing approaches for hormone replacement therapies. The market for gynecology is showing signs of a significant upward growth trend over the forecast period to 2017 and the next decade will be exciting, but companies will need to differentiate their products and consider the market forces that may affect product revenue and portfolios.
The World Market for Gynecology aims to provide an expert analysis of the prescription drug market for female health over the next decade based on current industrial insights, market factors and forces, and trend information. Study objectives include critical assessments of existing products, reviews of products in clinical development, therapy forecasting of product/portfolios to 2017, and market sector analytics by therapeutic category and discrete disorder.
The laparoscopic instruments market is projected to reach USD 11.68 Billion by 2021, growing at a CAGR of 8.9% during the forecast period of 2016 to 2021. Growth in the laparoscopic instruments market can be attributed to factors such as increasing investments in the laparoscopic instruments market, growing patient and physician preference for laparoscopic procedures as compared to open surgeries, rise in geriatric population, rise in prevalence of colorectal cancer and obesity which can be treated laparoscopically, and technological advances in the field of laparoscopic instruments. In the coming years, the laparoscopic instruments market is expected to witness the highest growth rate in the Asia-Pacific region. North America is expected to account for the largest share of the global laparoscopic instruments market in 2016. However, reduced Medicare payments to healthcare providers in the U.S., competition offered by robotic minimally invasive surgeries as an alternative to laparoscopic procedures, and dearth of trained physicians are likely to restrain the growth of the market during the forecast period.
The medical image analysis software market is expected to reach USD 3,135.3 Million by 2020 from USD 2,143.7 Million in 2015, at a CAGR of 7.9% from 2015 to 2020. Major factors driving the growth of this market include technological advancements, growing public- and private-sector investments, rapid growth in aging population, fusion of imaging technologies, growing applications of computer-aided diagnosis (CAD), rising incidences of chronic diseases, and increasing usage of imaging equipment. On the other hand, financial constraints, growing hacking-related risks associated with the use of medical equipment and software, and dearth of skilled professionals are the major factors restraining the growth of this market.
The global ultrasound market is expected to reach USD 6.86 Billion by 2020 from USD 5.25 Billion in 2015, at a CAGR of 5.5% from 2015 to 2020. Market growth can be attributed to the rising patient population base for chronic and lifestyle-related disorders (such as hypertension and vascular disorders) coupled with growing geriatric population; technological advancements; increasing public-private investments, funds, and grants; and growing market demand for minimally invasive disease diagnosis and treatment.
North America dominated the global market with a revenue share of 40.6% in 2014. High adoption rate of advanced technology and the presence of large market players in the region are some factors accounting for its large revenue share. The region is expected to maintain its dominance throughout the forecast period, mainly due to the growth in the number of new detected cases.
Government and healthcare agencies in North America are promoting routine check-ups to lower mortality rates associated with breast and cervical cancer patients since, early detection increases treatment success rates.
Asia Pacific is anticipated to witness lucrative growth during the forecast period. Growth in the inflow of patients owing to the rapidly booming medical tourism industry is expected to serve as the highest impact rendering driver.
Moreover, the presence of a large pool of skilled professionals, cheaper labor cost, and advance manufacturing facilities have resulted in the shifting of manufacturing facilities to China and India. As a result, the overall manufacturing costs of these devices have reduced. Therefore, manufacturers are now able to offer their products at lower cost.
Importance and Scope
Obstetrics deals with the care of pregnant women and the unborn child. Gynecology deals with the management of diseases that are specific to women. Many new techniques and procedures have been developed over years and improved the health of women and babies. The ultrasound devices have improved the care of the baby in the womb. It has been evolving in both molecular and clinical level with many researches. The research in Obstetrics and Gynecology lead to the discovery of maternal and fetal medicine, reproductive medicine, urogynaecology, gynecological oncology and reproductive health care.
Scope of the Report:
Commissioned by a market leader in Women’s and Sexual Health, this report uniquely provides a comprehensive analysis of current and pipeline gynecology products, which is not available elsewhere in the market literature; Provides a concise overview of the conditions and diseases related to gynecology including aetiology, epidemiology, and management; Complete description of existing products to include reviews of product characteristics, side effects, and sales performance; Extensive information on new gynecological drugs in the pipeline, including product characteristics, technologies, research status, and the results of clinical trials; Market analysis of the US and international markets for gynecological prescription products with therapy area and sales forecasts to 2017; Analysis of market dynamics for infertility, contraception, menstrual and gynecological disorders, and menopause; Product-focused appraisals and discussions for market potential and growth; Benchmark analytics for current research themes and future therapy areas; Evaluation of the key drivers and predictors of growth and innovation in gynecology; In-depth assessment of the commercial and drug development opportunities in the field. Reports on the status of existing and pipeline gynecology prescription products to 2017; Highlights the drug development strategies that are being employed by companies to sustain leadership; Provides a comprehensive description of gynecological and obstetric drugs currently on the market; Describes the pipelines and biological targets being pursued by a host of companies, both small and large; Assists in analyzing discovery programs of competitors and aids decision-making for in-house research and development; Provides critical information on how companies are reformulating hormonal drugs to solve market, clinical, and regulatory barriers; Provides market trend data of best- and least-performing gynecology products; Identifies niche markets where there is an unmet need for gynecological and obstetric therapeutics; Provides forecasts of products, therapy areas, and drug classes to 2017; Shows estimation of the global market for gynecology to include both hormonal and non-hormonal products.